Inventor
AGGEN JAMES
US16 patents
⚠️ This page may combine multiple inventors who share the name “AGGEN JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
10 patentsUS6693202B1Feb 17, 2004
Muscarinic receptor antagonists
THERAVANCE INC253 citations99
US6670376B1Dec 30, 2003
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC129 citations98
US7341993B2Mar 11, 2008
Cross-linked glycopeptide—cephalosporin antibiotics
THERAVANCE INC22 citations96
US6974797B2Dec 13, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC45 citations96
US7125892B2Oct 24, 2006
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC16 citations92
US6949568B2Sep 27, 2005
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC23 citations92
US7582765B2Sep 1, 2009
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC2 citations62
US7553971B2Jun 30, 2009
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC1 citations52
US7456203B2Nov 25, 2008
Muscarinic receptor antagonists
THERAVANCE INC1 citations52
US7452995B2Nov 18, 2008
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC0 citations52
KODIAK SCIENCES INC
5 patentsUS9840553B2Dec 12, 2017
Dual PDGF/VEGF antagonists
KODIAK SCIENCES INC18 citations89
US11590235B2Feb 28, 2023
Factor VIII zwitterionic polymer conjugates
KODIAK SCIENCES INC5 citations84
US11155610B2Oct 26, 2021
Dual PDGF/VEGF antagonists
KODIAK SCIENCES INC7 citations82
US10702608B2Jul 7, 2020
Factor VIII zwitterionic polymer conjugates
KODIAK SCIENCES INC10 citations82
US12214044B2Feb 4, 2025
Factor VIII zwitterionic polymer conjugates
KODIAK SCIENCES INC0 citations61